Researchers Discover Causes of Graft-Verus-Host-Disease
Source: Pixabay

Researchers Discover Causes of Graft-Verus-Host-Disease

Research into graft-versus-host-disease (GVHD), a condition that can occur after bone marrow transplants, has yielded promising results. A study, reported by BrightSurf, found that a particular group of microRNA molecules involved…

Continue Reading Researchers Discover Causes of Graft-Verus-Host-Disease
Patients Are Being Asked for Their Opinions on Treatments For Lysosomal Storage Diseases
Source: Pixabay

Patients Are Being Asked for Their Opinions on Treatments For Lysosomal Storage Diseases

In an effort to better understand patient experiences, researchers at the Massachusetts General Hospital are surveying people with lysosomal storage diseases about how they view their treatments, reports CheckOrphan. The…

Continue Reading Patients Are Being Asked for Their Opinions on Treatments For Lysosomal Storage Diseases
Researchers Identify Predictive Factors for Pulmonary Hypertension in Scleroderma Patients
Source: Pixabay

Researchers Identify Predictive Factors for Pulmonary Hypertension in Scleroderma Patients

Patients with a form of scleroderma called systemic sclerosis are particularly susceptible to developing high blood pressure in their heart and lungs, also known as pulmonary hypertension. A new study…

Continue Reading Researchers Identify Predictive Factors for Pulmonary Hypertension in Scleroderma Patients
A Treatment for Inherited Metabolic Disorders is Being Trialled in Patients
Source: Pixabay

A Treatment for Inherited Metabolic Disorders is Being Trialled in Patients

A new treatment under development has produced promising results in patients with blood cancers and is now being tested in inherited metabolic disorders, reports Financial Buzz. Inherited metabolic disorders are…

Continue Reading A Treatment for Inherited Metabolic Disorders is Being Trialled in Patients
Patients with Ankylosing Spondylitis Don’t Fully Trust Biosimilars
source: pixabay.com

Patients with Ankylosing Spondylitis Don’t Fully Trust Biosimilars

According to a story from ankylosingspondylitisnews.com, a significant proportion of patients stopped taking a biosimilar for infliximab within six months of transitioning to the new medication. This suggests that the…

Continue Reading Patients with Ankylosing Spondylitis Don’t Fully Trust Biosimilars
New Campaign Encourages Idiopathic Pulmonary Fibrosis Patients to Keep Exercising
Source: Pixabay.com

New Campaign Encourages Idiopathic Pulmonary Fibrosis Patients to Keep Exercising

According to a story from The Irish Times, a new campaign is encouraging people with the rare lung condition idiopathic pulmonary fibrosis to keep exercising. The campaign is centered around…

Continue Reading New Campaign Encourages Idiopathic Pulmonary Fibrosis Patients to Keep Exercising
Company Continues to Back an Experimental Therapy for Duchenne Muscular Dystrophy Despite Clinical Hold
source: pixabay.com

Company Continues to Back an Experimental Therapy for Duchenne Muscular Dystrophy Despite Clinical Hold

According to a story from genengnews.com, the pharmaceutical company Solid Biosciences is pledging to continue developing its investigation drug candidate SGT-001 for Duchenne muscular dystrophy. This is despite its clinical…

Continue Reading Company Continues to Back an Experimental Therapy for Duchenne Muscular Dystrophy Despite Clinical Hold